Skip to main content
Erschienen in: Digestive Diseases and Sciences 4/2014

01.04.2014 | Original Article

Different Peptic Ulcer Bleeding Risk in Chronic Kidney Disease and End-Stage Renal Disease Patients Receiving Different Dialysis

verfasst von: Kuang-Wei Huang, Hsin-Bang Leu, Jiing-Chyuan Luo, Wan-Leong Chan, Ming-Chih Hou, Han-Chieh Lin, Fa-Yauh Lee, Yi-Chun Kuan

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

End stage renal disease (ESRD) patients receiving hemodialysis (HD) have a higher risk of peptic ulcer bleeding (PUB).

Aims

Whether ESRD patients receiving peritoneal dialysis (PD) also carries a higher risk of PUB has not been studied.

Methods

This was a cohort study using Taiwan’s National Health Insurance research database, whereby 11,408 patients, including 2,239 PD, 2,328 HD, 2,267 chronic kidney disease (CKD) and 4,574 controls with age–sex matching were recruited. The log-rank test was used to analyze differences in accumulated PUB-free survival rates between groups. Cox proportional hazard regression was performed to evaluate independent risk factors for PUB in all the enrollees.

Results

During the 7-year follow-up, PD and CKD patients had a significantly higher rate of PUB than matched controls. The risk of PUB between PD and CKD was not significantly different. Moreover, patients receiving HD carried a higher risk of PUB than those receiving PD, with CKD and controls (p all <0.05, by log-rank test). Cox proportional hazard regression analysis showed that CKD (HR 3.99, 95 % CI 2.24–7.13), PD (HR 3.71, 95 % CI 2.00–6.87) and HD (HR 11.96, 95 % CI 7.04–20.31) were independently associated with an increased risk of PUB. Being elderly, male, having hypertension, diabetes, cirrhosis, and nonsteroidal anti-inflammatory drugs and steroid use were other independent risk factors of PUB in all enrollees.

Conclusions

Patients with CKD and ESRD receiving PD or HD carried a higher risk for PUB. They should be screened for risk factors for PUB and receive some protective measures to prevent PUB.
Literatur
1.
Zurück zum Zitat US Renal Data System (USRDS). Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009. US Renal Data System (USRDS). Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009.
3.
Zurück zum Zitat Kong SX, Hatoum HT, Zhao SZ, Agrawal NM, Geis SG. Prevalence and cost of hospitalization for gastrointestinal complications related to peptic ulcers with bleeding or perforation: comparison of two national databases. Am J Manag Care. 1998;4:399–409.PubMed Kong SX, Hatoum HT, Zhao SZ, Agrawal NM, Geis SG. Prevalence and cost of hospitalization for gastrointestinal complications related to peptic ulcers with bleeding or perforation: comparison of two national databases. Am J Manag Care. 1998;4:399–409.PubMed
4.
Zurück zum Zitat Barkun A, Leontiadis G. Systematic review of the symptom burden, quality of life impairment and costs associated with peptic ulcer disease. Am J Med. 2010;123:e2.PubMedCrossRef Barkun A, Leontiadis G. Systematic review of the symptom burden, quality of life impairment and costs associated with peptic ulcer disease. Am J Med. 2010;123:e2.PubMedCrossRef
5.
Zurück zum Zitat Xia HH, Phung N, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci. 2001;46:2716–2723. doi:10.1023/A:1012731614075.PubMedCrossRef Xia HH, Phung N, Altiparmak E, Berry A, Matheson M, Talley NJ. Reduction of peptic ulcer disease and Helicobacter pylori infection but increase of reflux esophagitis in Western Sydney between 1990 and 1998. Dig Dis Sci. 2001;46:2716–2723. doi:10.​1023/​A:​1012731614075.PubMedCrossRef
6.
Zurück zum Zitat Xia B, Xia HH, Ma CW, et al. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment Pharmacol Ther. 2005;22:243–249.PubMedCrossRef Xia B, Xia HH, Ma CW, et al. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment Pharmacol Ther. 2005;22:243–249.PubMedCrossRef
7.
Zurück zum Zitat Luo JC, Leu HB, Huang KW, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ. 2011;183:E1345–E1351.PubMedCentralPubMedCrossRef Luo JC, Leu HB, Huang KW, et al. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ. 2011;183:E1345–E1351.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut. 2011;60:1038–1042.PubMedCrossRef Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut. 2011;60:1038–1042.PubMedCrossRef
9.
Zurück zum Zitat Huang KW, Luo JC, Leu HB, et al. Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study. Aliment Pharmacol Ther. 2012;35:796–802.PubMedCrossRef Huang KW, Luo JC, Leu HB, et al. Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study. Aliment Pharmacol Ther. 2012;35:796–802.PubMedCrossRef
10.
Zurück zum Zitat Luo JC, Leu HB, Hou MC, et al. Non-peptic ulcer, non-variceal gastrointestinal bleeding in hemodialysis patients. Am J Med. 2013;126:264.e25–264.e32.CrossRef Luo JC, Leu HB, Hou MC, et al. Non-peptic ulcer, non-variceal gastrointestinal bleeding in hemodialysis patients. Am J Med. 2013;126:264.e25–264.e32.CrossRef
11.
Zurück zum Zitat Luo JC, Leu HB, Hou MC, et al. Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study. Aliment Pharmacol Ther. 2012;36:542–550.PubMedCrossRef Luo JC, Leu HB, Hou MC, et al. Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study. Aliment Pharmacol Ther. 2012;36:542–550.PubMedCrossRef
12.
Zurück zum Zitat Doherty CC, O’Connor FA, Buchanan KD, Sloan JM, Douglas JF, McGeown MG. Treatment of peptic ulcer in renal failure. Proc Eur Dial Transplant Assoc. 1977;14:386–395.PubMed Doherty CC, O’Connor FA, Buchanan KD, Sloan JM, Douglas JF, McGeown MG. Treatment of peptic ulcer in renal failure. Proc Eur Dial Transplant Assoc. 1977;14:386–395.PubMed
13.
Zurück zum Zitat Kang JY, Ho KY, Yeoh KG, et al. Peptic ulcer and gastritis in uraemia, with particular reference to the effect of Helicobacter pylori infection. J Gastroenterol Hepatol. 1999;14:771–778.PubMedCrossRef Kang JY, Ho KY, Yeoh KG, et al. Peptic ulcer and gastritis in uraemia, with particular reference to the effect of Helicobacter pylori infection. J Gastroenterol Hepatol. 1999;14:771–778.PubMedCrossRef
14.
Zurück zum Zitat Tseng GY, Lin HJ, Fang CT, et al. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study. Aliment Pharmacol Ther. 2007;26:925–933.PubMedCrossRef Tseng GY, Lin HJ, Fang CT, et al. Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: a 2-year study. Aliment Pharmacol Ther. 2007;26:925–933.PubMedCrossRef
15.
Zurück zum Zitat Chen YT, Yang WC, Lin CC, Ng YY, Chen JY, Li SY. Comparison of peptic ulcer disease risk between peritoneal and hemodialysis patients. Am J Nephrol. 2010;32:212–218.PubMedCrossRef Chen YT, Yang WC, Lin CC, Ng YY, Chen JY, Li SY. Comparison of peptic ulcer disease risk between peritoneal and hemodialysis patients. Am J Nephrol. 2010;32:212–218.PubMedCrossRef
16.
Zurück zum Zitat Lee SW, Song JH, Kim GA, Yang HJ, Lee KJ, Kim MJ. Effect of dialysis modalities on gastric myoelectrical activity in end-stage renal disease patients. Am J Kidney Dis. 2000;36:566–573.PubMedCrossRef Lee SW, Song JH, Kim GA, Yang HJ, Lee KJ, Kim MJ. Effect of dialysis modalities on gastric myoelectrical activity in end-stage renal disease patients. Am J Kidney Dis. 2000;36:566–573.PubMedCrossRef
17.
Zurück zum Zitat Kerrigan DD, Read NW, Houghton LA, Taylor ME, Johnson AG. Disturbed gastroduodenal motility in patients with active and healed duodenal ulceration. Gastroenterology. 1991;100:892–900.PubMed Kerrigan DD, Read NW, Houghton LA, Taylor ME, Johnson AG. Disturbed gastroduodenal motility in patients with active and healed duodenal ulceration. Gastroenterology. 1991;100:892–900.PubMed
18.
Zurück zum Zitat Kamiya T, Kobayashi Y, Hirako M, et al. Gastric motility in patients with recurrent gastric ulcers. J Smooth Muscle Res. 2002;38:1–9.PubMedCrossRef Kamiya T, Kobayashi Y, Hirako M, et al. Gastric motility in patients with recurrent gastric ulcers. J Smooth Muscle Res. 2002;38:1–9.PubMedCrossRef
19.
Zurück zum Zitat Borazan A, Cavdar Z, Saglam F. The effect of renal replacement therapies on serum gastrointestinal system hormones. Ren Fail. 2007;29:1019–1023.PubMedCrossRef Borazan A, Cavdar Z, Saglam F. The effect of renal replacement therapies on serum gastrointestinal system hormones. Ren Fail. 2007;29:1019–1023.PubMedCrossRef
20.
Zurück zum Zitat Aguilera A, Bajo MA, Espinoza M, et al. Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities. Am J Kidney Dis. 2003;42:787–796.PubMedCrossRef Aguilera A, Bajo MA, Espinoza M, et al. Gastrointestinal and pancreatic function in peritoneal dialysis patients: their relationship with malnutrition and peritoneal membrane abnormalities. Am J Kidney Dis. 2003;42:787–796.PubMedCrossRef
21.
Zurück zum Zitat Fourmy D, Gigoux V, Reubi JC. Gastrin in gastrointestinal diseases. Gastroenterology. 2011;141:e1–e3.PubMedCrossRef Fourmy D, Gigoux V, Reubi JC. Gastrin in gastrointestinal diseases. Gastroenterology. 2011;141:e1–e3.PubMedCrossRef
22.
Zurück zum Zitat Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW, Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis. 2004;43:891–899.PubMedCrossRef Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW, Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis. 2004;43:891–899.PubMedCrossRef
23.
Zurück zum Zitat Stack AG. Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol. 2002;13:1279–1287.PubMed Stack AG. Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol. 2002;13:1279–1287.PubMed
24.
Zurück zum Zitat Kendix M. Dialysis modality selection among patients attending freestanding dialysis facilities. Health Care Financ Rev. 1997;18:3–21.PubMed Kendix M. Dialysis modality selection among patients attending freestanding dialysis facilities. Health Care Financ Rev. 1997;18:3–21.PubMed
25.
Zurück zum Zitat Liang CH, Yang CY, Lu KC, et al. Factors affecting peritoneal dialysis selection in Taiwanese patients with chronic kidney disease. Int Nurs Rev. 2011;58:463–469.PubMedCrossRef Liang CH, Yang CY, Lu KC, et al. Factors affecting peritoneal dialysis selection in Taiwanese patients with chronic kidney disease. Int Nurs Rev. 2011;58:463–469.PubMedCrossRef
26.
Zurück zum Zitat Tam P. Peritoneal dialysis and preservation of residual renal function. Perit Dial Int. 2009;29:S108–S110.PubMed Tam P. Peritoneal dialysis and preservation of residual renal function. Perit Dial Int. 2009;29:S108–S110.PubMed
27.
Zurück zum Zitat Radulescu D, Ferechide D. The importance of residual renal function in chronic dialysed patients. J Med Life. 2009;2:199–206.PubMedCentralPubMed Radulescu D, Ferechide D. The importance of residual renal function in chronic dialysed patients. J Med Life. 2009;2:199–206.PubMedCentralPubMed
28.
Zurück zum Zitat Pecoits-Filho R, Heimbürger O, Bárány P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003;41:1212–1218.PubMedCrossRef Pecoits-Filho R, Heimbürger O, Bárány P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis. 2003;41:1212–1218.PubMedCrossRef
29.
Zurück zum Zitat Marques de Mattos A, Marino LV, Ovidio PP, Jordão AA, Almeida CC, Chiarello PG. Protein oxidative stress and dyslipidemia in dialysis patients. Ther Apher Dial. 2012;16:68–74.PubMedCrossRef Marques de Mattos A, Marino LV, Ovidio PP, Jordão AA, Almeida CC, Chiarello PG. Protein oxidative stress and dyslipidemia in dialysis patients. Ther Apher Dial. 2012;16:68–74.PubMedCrossRef
30.
Zurück zum Zitat Samouilidou EC, Grapsa EJ, Kakavas I, Lagouranis A, Agrogiannis B. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Int Urol Nephrol. 2003;35:393–397.PubMedCrossRef Samouilidou EC, Grapsa EJ, Kakavas I, Lagouranis A, Agrogiannis B. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Int Urol Nephrol. 2003;35:393–397.PubMedCrossRef
31.
Zurück zum Zitat Kang JM, Kim N, Kim JH, et al. Effect of aging on gastric mucosal defense mechanisms: ROS, apoptosis, angiogenesis, and sensory neurons. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1147–G1153.PubMedCrossRef Kang JM, Kim N, Kim JH, et al. Effect of aging on gastric mucosal defense mechanisms: ROS, apoptosis, angiogenesis, and sensory neurons. Am J Physiol Gastrointest Liver Physiol. 2010;299:G1147–G1153.PubMedCrossRef
32.
Zurück zum Zitat Ethier J, Bragg-Gresham JL, Piera L, et al. Aspirin prescription and outcomes in hemodialysis patients: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2007;50:602–611.PubMedCrossRef Ethier J, Bragg-Gresham JL, Piera L, et al. Aspirin prescription and outcomes in hemodialysis patients: the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2007;50:602–611.PubMedCrossRef
33.
Zurück zum Zitat Jankovic SM, Aleksic J, Rakovic S, et al. Non-steroidal antiinflammatory drugs and risk of gastro-intestinal bleeding among patients on hemodialysis. J Nephrol. 2009;22:502–507.PubMed Jankovic SM, Aleksic J, Rakovic S, et al. Non-steroidal antiinflammatory drugs and risk of gastro-intestinal bleeding among patients on hemodialysis. J Nephrol. 2009;22:502–507.PubMed
34.
Zurück zum Zitat Steinhauer HB, Gunter B, Schollmeyer P. Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Invest. 1985;15:1–5.PubMedCrossRef Steinhauer HB, Gunter B, Schollmeyer P. Stimulation of peritoneal synthesis of vasoactive prostaglandins during peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Invest. 1985;15:1–5.PubMedCrossRef
35.
Zurück zum Zitat Luo JC, Shin VY, Liu ES, et al. Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats. J Pharmacol Exp Ther. 2003;307:692–698.PubMedCrossRef Luo JC, Shin VY, Liu ES, et al. Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats. J Pharmacol Exp Ther. 2003;307:692–698.PubMedCrossRef
36.
Zurück zum Zitat Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002;359:14–22.PubMedCrossRef Huang JQ, Sridhar S, Hunt RH. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet. 2002;359:14–22.PubMedCrossRef
37.
Zurück zum Zitat Shousha S, Arnaout AH, Abbas SH, Parkins RA. Antral Helicobacter pylori in patients with chronic renal failure. J Clin Pathol. 1990;43:397–399.PubMedCentralPubMedCrossRef Shousha S, Arnaout AH, Abbas SH, Parkins RA. Antral Helicobacter pylori in patients with chronic renal failure. J Clin Pathol. 1990;43:397–399.PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int. 2009;75:96–103.PubMedCentralPubMedCrossRef Sugimoto M, Sakai K, Kita M, Imanishi J, Yamaoka Y. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int. 2009;75:96–103.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol. 1997;24:2–17.PubMedCrossRef Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol. 1997;24:2–17.PubMedCrossRef
Metadaten
Titel
Different Peptic Ulcer Bleeding Risk in Chronic Kidney Disease and End-Stage Renal Disease Patients Receiving Different Dialysis
verfasst von
Kuang-Wei Huang
Hsin-Bang Leu
Jiing-Chyuan Luo
Wan-Leong Chan
Ming-Chih Hou
Han-Chieh Lin
Fa-Yauh Lee
Yi-Chun Kuan
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 4/2014
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2973-6

Weitere Artikel der Ausgabe 4/2014

Digestive Diseases and Sciences 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.